- Home
- SKWD
as 02-21-2025 4:00pm EST
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.
Upcoming Earnings Alert:
Get ready for potential market movements as Skyward Specialty Insurance Group Inc. SKWD prepares to release earnings report on 25 Feb 2025.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 2.0B | IPO Year: | 2023 |
| Target Price: | $53.00 | AVG Volume (30 days): | 386.9K |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 3.27 | EPS Growth: | 54.99 |
| 52 Week Low/High: | $33.27 - $55.62 | Next Earning Date: | 02-25-2025 |
| Revenue: | $1,092,093,000 | Revenue Growth: | 32.05% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 12.02% |
Stock Insider Trading Activity of Skyward Specialty Insurance Group Inc. (SKWD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Robinson Andrew S | SKWD | CHAIRMAN & CEO | Jan 7 '25 | Sell | $45.34 | 11,274 | $510,693.60 | 53,911 | |
| Schmitt Thomas N | SKWD | CHIEF PEOPLE & ADMIN. OFFICER | Jan 3 '25 | Sell | $47.33 | 1,183 | $56,035.43 | 10,246 | |
| Shaunty Leslie | SKWD | GENERAL COUNSEL & SECRETARY | Jan 3 '25 | Sell | $47.40 | 801 | $38,005.84 | 20,751 | |
| Robinson Andrew S | SKWD | CHAIRMAN & CEO | Jan 2 '25 | Sell | $47.81 | 19,525 | $942,231.35 | 53,911 | |
| Hill Kirby | SKWD | PRESIDENT - INDUSTRY SOLUTIONS | Jan 2 '25 | Sell | $49.00 | 1,560 | $76,446.24 | 8,786 | |
| Burkhart John A III | SKWD | PRESIDENT - SPECIALTY LINES | Jan 2 '25 | Sell | $49.04 | 1,465 | $71,843.60 | 14,042 | |
| Bodnar Dan PK | SKWD | CHIEF INFORMATION OFFICER | Jan 2 '25 | Sell | $49.49 | 3,484 | $173,238.33 | 15,161 | |
| HAUSHILL MARK W | SKWD | EVP & CFO | Jan 2 '25 | Sell | $49.06 | 1,630 | $79,964.54 | 176,971 | |
| Kapadia Sandip A | SKWD | EVP, CHIEF ACTUARY | Jan 2 '25 | Sell | $47.79 | 6,484 | $316,548.00 | 12,508 | |
| Duffy Sean W | SKWD | EVP & CHIEF CLAIMS OFFICER | Jan 2 '25 | Sell | $49.02 | 1,475 | $72,304.50 | 8,455 |
Latest Skyward Specialty Insurance Group Inc. News
SKWD Breaking Stock News: Dive into SKWD Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Why Skyward (SKWD) Could Beat Earnings Estimates Again
Zacks
2 days ago
Insights Into Skyward (SKWD) Q4: Wall Street Projections for Key Metrics
Insider Monkey
3 days ago
Why Skyward Specialty Insurance Group Inc. (SKWD) is the Most Undervalued Small-Cap Stock to Invest In
Insider Monkey
4 days ago
Skyward Specialty Insurance Group (SKWD): Among Top Insider Stock Buys And Sells In January
Insider Monkey
8 days ago
Skyward Specialty (SKWD): Among The Small–Cap Stocks Insiders Are Selling Recently
Zacks
15 days ago
Skyward (SKWD) Upgraded to Buy: Here's What You Should Know
Zacks
15 days ago
Skyward Specialty Insurance (SKWD) Just Overtook the 50-Day Moving Average
Investor's Business Daily
16 days ago
Kemper Stock Gets IBD Rating Upgrade
Compare SKWD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SKWD Skyward Specialty Insurance Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.